| T1DM | T2DMBOT | T2DMB/B | ||||||
---|---|---|---|---|---|---|---|---|---|
Degludec (BGN/year) | Glargine U100 (BGN/year) | Incremental cost (BGN/year) | Degludec (BGN/year) | Glargine U100 (BGN/year) | Incremental cost (BGN/year) | Degludec (BGN/year) | Glargine U100 (BGN/year) | Incremental cost (BGN/year) | |
Insulin | 1296.67 | 1180.11 | 116.56 | 794.93 | 574.23 | 220.70 | 1574.88 | 1196.94 | 377.95 |
Hypoglycaemia events | 1846.61 | 1893.80 | −47.19 | 306.40 | 509.74 | − 203.34 | 581.79 | 655.53 | −73.74 |
Non-severe daytime events | 19.42 | 19.42 | 0.00 | 15.02 | 15.02 | 0.00 | 16.35 | 19.69 | −3.35 |
Non-severe nocturnal events | 230.41 | 277.60 | −47.19 | 284.26 | 443.94 | − 159.68 | 211.17 | 281.56 | −70.39 |
Severe events | 1596.78 | 1596.78 | 0.00 | 7.11 | 50.78 | −43.67 | 354.28 | 354.28 | 0.00 |
Total costs | 3143.28 | 3073.92 | 69.37 | 1101.32 | 1083.97 | 17.35 | 2156.67 | 1852.47 | 304.21 |
QALYs | 0.5722 | 0.5568 | 0.0154 | 0.7490 | 0.7055 | 0.0435 | 0.6893 | 0.6480 | 0.0413 |
ICER (cost/QALY) | 4498.68 | Â | Â | 399.11 | Â | Â | 7365.22 | Â | Â |